Mohamed Hebbar - Concepedia

Author

Mohamed Hebbar

Also Known As

Denis Smith, Eric Terrebonne, Hebbar Mohamed, Hebbar, M., Laurent Bedenne, M HEBBAR, M Hebbar, M. HEBBAR, M. Hebbar, MOHAMED HEBBAR

277

Publications

10.2K

Citations

H-Index

Concepts

All Affiliations

Inserm Hôpital Claude Huriez Centre Oscar Lambret Université de Lille Sorbonne Université

About

Mohamed Hebbar is an author at Inserm specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	45	2.9K
2	Health Sciences	8	8	351
3	Engineering	2	2	333
4	Natural Sciences	1	1	154
5	Allergy	1	1	24

Mohamed Hebbar

Publications

9.1K

Citations

H-Index

Page 1

	Year	Citations
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer Thierry Conroy, Pascal Hammel, Mohamed Hebbar, New England Journal of Medicine	2018	2.7K
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells Dorothée Duluc, Yves Delneste, Fang Tan, Blood	2007	468
Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis Yasmine Touil, Wassila Igoudjil, Matthieu Corvaisier, Clinical Cancer Research	2013	332
Interferon‐γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor‐associated macrophages Dorothée Duluc, Murielle Corvaisier, Simon Blanchard, International Journal of Cancer Tumor-associated MacrophagesImmunologyImmunologic MechanismImmune SystemImmunotherapy	2009	314
Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Pascal Morel, Mohamed Hebbar, J L Laï, PubMed	1993	303
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial Charles S. Fuchs, Kohei Shitara, Maria Di Bartolomeo, The Lancet Oncology First-line TherapyGastrointestinal OncologyMedicinePathologyMetastatic Gastric	2019	276
The Impact of Perioperative Chemotherapy on Survival in Patients With Gastric Signet Ring Cell Adenocarcinoma Mathieu Messager, Jérémie H. Lefèvre, Virginie Pichot-Delahaye, Annals of Surgery	2011	201
Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. M.-A. Recchi, Mohamed Hebbar, Louis Hornez, PubMed Breast OncologyEngineeringHuman Breast CancerCancer BiologyCancer Cell Biology	1998	168
Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay. Valérie Pawlowski, Françoise Révillion, Mohamed Hebbar, PubMed Egfr ExpressionBreast OncologyEngineeringLarge SeriesPathology	2000	165
Capecitabine plus oxaliplatin (XELOX) <i>versus</i> 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) as first‐line treatment for metastatic colorectal cancer Michel Ducreux, Jaafar Bennouna, Mohamed Hebbar, International Journal of Cancer	2010	164

Page 1